Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study

Sampath V, Abrams EM, Adlou B, Akdis C, Akdis M, Brough HA, et al. Food allergy across the globe. J Allergy Clin Immunol. 2021;148(6):1347–64.

Article  PubMed  Google Scholar 

Shaker M, Mauger D, Fuhlbrigge AL. Value-based, cost-effective care: the role of the allergist-immunologist. J Allergy Clin Immunol Pract. 2022;11(1):132–9.

Article  PubMed  Google Scholar 

Protudjer JLP, Venter C, Groetch M, Frykas TLM, Lidington J, Kim H. The need for a food allergy educator program for allied healthcare professionals in Canada. Allergy Asthma Clin Immunol. 2022;18(1):62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, et al. Food allergy: a practice parameter update—2014. J Allergy Clin Immunol. 2014;134(5):1016-1025.e43.

Article  PubMed  Google Scholar 

Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017;139(1):173-181.e8.

Article  CAS  PubMed  Google Scholar 

Klemans RJB, Otte D, Knol M, Knol EF, Meijer Y, Gmelig-Meyling FHJ, et al. The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model. J Allergy Clin Immunol. 2013;131(1):157–63.

Article  CAS  PubMed  Google Scholar 

Chua GT, Greenhawt M, Shaker M, Soller L, Abrams EM, Cameron SB, et al. The case for prompt salvage infant peanut oral immunotherapy following failed primary prevention. J Allergy Clin Immunol Pract. 2022;10(10):2561–9.

Article  PubMed  Google Scholar 

Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, et al. Effect of avoidance on peanut allergy after early peanut consumption. N Engl J Med. 2016;374(15):1435–43.

Article  PubMed  Google Scholar 

Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803–13.

Article  PubMed  PubMed Central  Google Scholar 

Conroy E, Ponda P. How primary care providers can help prevent food allergies. Curr Opin Pediatr. 2022;34(4):430–7.

Article  PubMed  Google Scholar 

Chan ES, Dinakar C, Gonzales-Reyes E, Green TD, Gupta R, Jones D, et al. Unmet needs of children with peanut allergy. Ann Allergy Asthma Immunol. 2020;124(5):479–86.

Article  CAS  PubMed  Google Scholar 

Cafarotti A, Giovannini M, Begìn P, Brough HA, Arasi S. Management of IgE-mediated food allergy in the 21st century. Clin Exp Allergy. 2023;53(1):25–38.

Article  CAS  PubMed  Google Scholar 

Soller L, Carr S, Kapur S, Rex GA, McHenry M, Cook VE, et al. Real-world peanut OIT in infants may be safer than non-infant preschool OIT and equally effective. J Allergy Clin Immunol Pract. 2022;10(4):1113-1116.e1.

Article  PubMed  Google Scholar 

Jones SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, Wood RA, Sampson HA, et al. Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet. 2022;399(10322):359–71.

Article  CAS  PubMed  Google Scholar 

Wasserman RL, Factor J, Windom HH, Abrams EM, Begin P, Chan ES, et al. An approach to the office-based practice of food oral immunotherapy. J Allergy Clin Immunol Pract. 2021;9(5):1826-1838.e8.

Article  PubMed  Google Scholar 

Bégin P, Chan ES, Kim H, Wagner M, Cellier MS, Favron-Godbout C, et al. CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy Asthma Clin Immunol. 2020;16(1):20.

Article  PubMed  PubMed Central  Google Scholar 

Soller L, Abrams EM, Carr S, Kapur S, Rex GA, Leo S, et al. First real-world safety analysis of preschool peanut oral immunotherapy. J Allergy Clin Immunol Pract. 2019;7(8):2759-2767.e5.

Article  PubMed  Google Scholar 

Greenhawt M, Shaker M, Abrams EM. Peanut oral immunotherapy in very young children. The Lancet. 2022;399(10322):336–7.

Article  Google Scholar 

Chinthrajah RS, Purington N, Andorf S, Long A, O’Laughlin KL, Lyu SC, et al. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. Lancet. 2019;394(10207):1437–49.

Article  PubMed  PubMed Central  Google Scholar 

Shaker M, Chan ES, Protudjer JLP, Soller L, Abrams EM, Greenhawt M. The cost-effectiveness of preschool peanut oral immunotherapy in the real-world setting. J Allergy Clin Immunol Pract. 2021;9(7):2876-2884.e4.

Article  CAS  PubMed  Google Scholar 

Mack DP, Soller L, Chan ES, Hanna MA, Terpstra C, Vander Leek TK, et al. A high proportion of canadian allergists offer oral immunotherapy but barriers remain. J Allergy Clin Immunol Pract. 2021;9(5):1902–8.

Article  CAS  PubMed  Google Scholar 

Lee E, Song C, Vadas P, Morgan M, Betschel S. Retrospective analysis of synchronous telemedicine use in clinical immunology and allergy (CIA): a population-based cohort study in Ontario, Canada. J Allergy Clin Immunol. 2021;147(2):AB112.

Article  Google Scholar 

Chua GT, Chan ES, Soller L, Cook VE, Vander Leek TK, Mak R. Home-based peanut oral immunotherapy for low-risk peanut-allergic preschoolers during the COVID-19 pandemic and beyond. Front Allergy. 2021;2: 725165.

Article  PubMed  PubMed Central  Google Scholar 

Vassar M, Matthew H. The retrospective chart review: important methodological considerations. J Educ Eval Health Prof. 2013;10:12.

Article  PubMed  Google Scholar 

Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process: Table 1. BMJ Qual Saf. 2016;25(12):986–92.

Article  PubMed  Google Scholar 

Abrams EM, Erdle SC, Cameron SB, Soller L, Chan ES. How to incorporate oral immunotherapy into your clinical practice. Curr Allergy Asthma Rep. 2021;21(4):30.

Article  PubMed  Google Scholar 

Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the world allergy organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol. 2010;125(3):569-574.e7.

Article  PubMed  Google Scholar 

Keet CA, Berin MC. The year in food allergy. J Allergy Clin Immunol. 2022;149(3):867–73.

Article  PubMed  Google Scholar 

Soller L, Abrams EM, Carr S, Kapur S, Rex GA, Leo S, et al. First real-world effectiveness analysis of preschool peanut oral immunotherapy. J Allergy Clin Immunol Pract. 2021;9(3):1349-1356.e1.

Article  CAS  PubMed  Google Scholar 

Wasserman RL, Factor JM, Baker JW, Mansfield LE, Katz Y, Hague AR, et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract. 2014;2(1):91-96.e2.

Article  PubMed  Google Scholar 

Wasserman RL, Hague AR, Pence DM, Sugerman RW, Silvers SK, Rolen JG, et al. Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients. J Allergy Clin Immunol Pract. 2019;7(2):418-426.e4.

Article  PubMed  Google Scholar 

Erdle SC, Cook VE, Cameron SB, Yeung J, Kapur S, McHenry M, et al. Real-world safety analysis of preschool tree nut oral immunotherapy. J Allergy Clin Immunol Pract. 2023;11(4):1177–83.

Article  CAS  PubMed  Google Scholar 

Peters RL, Allen KJ, Dharmage SC, Koplin JJ, Dang T, Tilbrook KP, et al. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population-based assessment. J Allergy Clin Immunol. 2015;135(5):1257-1266.e2.

Article 

留言 (0)

沒有登入
gif